The Influence of Blood Collection Tubes in Biomarkers’ Screening by Mass Spectrometry

Purpose Mass spectrometry is one of the rapidly developing bio‐analytical techniques in recent years, and it shows that the results of biomarkers’ screening can be influenced by pre‐analytical process. The selection of the blood collection tubes is one of the most significant steps of pre‐analytical process which is often neglected by researchers. So, it is urgent to define the influence of blood collection tubes clearly in biomarkers’ screening. Experimental Design Two types of blood collection tubes, non‐additive tubes and coagulant activator tubes, are used to collect serum samples from patients and healthy controls. All samples are analyzed using matrix‐assisted laser desorption ionization‐time of flight mass spectrum in this study. Results The serum protein profile changes while using coagulant tubes whether for patients or healthy controls. It is found that the effect of coagulant on serum protein of patients is smaller than that of control group. There are 27 significantly different peaks between the control group and the control coagulant group. However, between patient group and patient coagulant group, only one differential peak is obtained. Coagulant changes the expression differences between patients and healthy controls, making the differences expand, shrink or reverse, and most of the polypeptides are small molecule, which will change the results of biomarker's screening. Conclusions and Clinical Relevance This research suggested that different types of blood collection tubes would influence the final laboratory results. So it's important for clinicians to choose the proper tubes to detect biomarkers and make correct diagnoses.